| COVID-19 Vaccine |
1 |
1 |
| Vaccines |
0 |
0.9 |
| Biologic Therapy |
0 |
0.83 |
| Patient Safety |
0 |
0.7 |
| Monoclonal Antibody |
0 |
0.67 |
| Food and Drug Administration (FDA) |
0 |
0.48 |
| Hospital |
0 |
0.34 |
| Adverse Effects |
0 |
0.24 |
| Grant |
0 |
0.19 |
| Immunization |
0 |
0.95 |
| Pandemic |
0 |
0.96 |
| Texas |
0 |
0.14 |
| COVID-19 |
0 |
0.97 |
| Florida |
0 |
0.1 |
| Tennessee |
0 |
0.1 |
| Otolaryngology |
0 |
0.07 |
| Alabama |
0 |
0.05 |
| Cancer |
0 |
0.05 |
| Clinical Research |
0 |
0.05 |
| Clinician Health and Well-Being |
0 |
0.05 |
| Cough |
0 |
0.05 |
| Dorsum |
0 |
0.05 |
| Georgia |
0 |
0.05 |
| Louisiana |
0 |
0.05 |
| Measles |
0 |
0.05 |
| Mississippi |
0 |
0.05 |
| New York |
0 |
0.05 |
| Outpatient Clinic |
0 |
0.05 |
| Shock |
0 |
0.05 |
| Surgery |
0 |
0.05 |
| Health Care Reform |
0 |
0.04 |
| Pediatric Respiratory Infections |
0 |
0.04 |
| Antibiotics |
0 |
0.02 |
| Medical Life |
0 |
0.02 |
| Trump and Healthcare |
0 |
0.02 |